MARKET

KNBIF

KNBIF

Kane Biotech Inc
OTCMQB
0.090
NaN%
Closed 09:30 04/19 EDT
OPEN
--
PREV CLOSE
0.090
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.188
52 WEEK LOW
0.042
MARKET CAP
11.84M
P/E (TTM)
-3.0033
1D
5D
1M
3M
1Y
5Y
Kane Biotech to Host Investor Webinar
Barchart · 4d ago
KANE BIOTECH ANNOUNCES CLOSING OF THE SALE OF STEM ANIMAL HEALTH TO DECHRA VETERINARY PRODUCTS
Reuters · 4d ago
Weekly Report: what happened at KNBIF last week (0408-0412)?
Weekly Report · 5d ago
KANE BIOTECH INC: ANTICIPATES USING NET PROCEEDS FROM TRANSACTION TO REPAY ITS OUTSTANDING LOAN TO PIVOT FINANCIAL I LIMITED PARTNERSHIP
Reuters · 04/11 13:45
Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health
Kane Biotech Inc. Has reached an agreement in principle for the sale of its entire interest in STEM Animal Health Inc. To a third party pharmaceutical company for US $8,000,000. The sale is expected to net Kane Biotech in excess of $11,500,000 .
Barchart · 04/11 08:45
Weekly Report: what happened at KNBIF last week (0401-0405)?
Weekly Report · 04/08 12:23
Weekly Report: what happened at KNBIF last week (0325-0329)?
Weekly Report · 04/01 12:20
Kane Biotech GAAP EPS of -$0.01
Kane Biotech Inc. Reports Q4 GAAP EPS of -$0.01. Total revenue for the three months ended December 31, 2023 was $764,997, an increase of 11% over the same period in 2022. Kane Biotech's stock is trading at $0.02.
Seeking Alpha · 03/26 20:46
More
About KNBIF
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the development and commercialization of products that prevent and remove microbial biofilms. The Company's technologies include DispersinB, AloSera, Aledex, Strix NB, bluestem and KBI Disinfectant. It is focused on the companion animal market with Strix NB brand for the veterinary segment and bluestem brand for the pet over the counter (OTC) retail market. The Company markets its oral care technology into the Canadian pet specialty market under the bluestem brand. It has over 100 pet specialty stores in Canada, which are engaged in selling the bluestem oral health products. It has various formulations in development, including formulations with antibiotics and the antibiofilm enzyme beta-N-Acetylglucosaminidase and antibiofilm-antimicrobial formulations for both the veterinary and human markets. It is focused on the development of oral care spray formulation and a water additive powder formulation.

Webull offers Kane Biotech Inc stock information, including OTCMQB: KNBIF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KNBIF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KNBIF stock methods without spending real money on the virtual paper trading platform.